Medpage Today on MSN5mon
FDA Expands Approval of Osimertinib in Lung Cancer
The FDA has approved osimertinib (Tagrisso) for locally advanced ... Patients were randomized 2:1 to receive oral osimertinib ...
FiercePharma23d
An additional treatment option with TAGRISSO® (osimertinib)
Arun Krishna, Vice President and franchise head for an AstraZeneca US OBU, shares details of a treatment option with TAGRISSO ® (osimertinib). AstraZeneca is focused on the development of new ...
National Institute for Health and Care Excellence8d
Osimertinib for adjuvant treatment of EGFR mutation-positive non-small-cell lung cancer after complete tumour resection
Osimertinib (Tagrisso, AstraZeneca) is indicated for 'adjuvant treatment following complete tumour resection in adults with stage IB to IIIA NSCLC whose tumours have EGFR exon 19 deletions or exon 21 ...